A new technology for management of diabetes is cost-effective for patients in the US with type 1 diabetes compared with traditional treatments.

Time in range metrics were similar, if not better, among older vs younger adults with T1D using automated insulin delivery systems.

Dexcom has been cash flow positive for since 2014 and more recently moved into positive earnings territory. While revenue has grown very quickly, research and development expenses and selling, general ...

CBSE allows students with Type 1 diabetes to carry insulin pumps and glucometers, highlighting the need for paediatric ...

Ensuring accuracy by force measurement and material testing is a necessary requirement in most every industry, especially orthopaedic and medical parts manufacturing where the highest quality control ...

Microbot reported positive data on its single-use endovascular robot. Elsewhere, GE Healthcare named a new business leader, and Puzzle Medical Devices raised $31 million.